Beyond the Broadcast: Expert Insights on SGLT2 Inhibitors in Cardiometabolic Care
Melissa Magwire, RN, MSN, CDE
Matthew Bullington, PharmD
Dawn M. Denicola, FNP-C
Keith Miller, MD
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
Vallerie V. McLaughlin, MD
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
Mazen Hanna, MD
Cardiorenal Collaboration: Escape the Treatment Trap
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
Pablo Garcia-Pavia, MD, PhD
Francesco Cappelli, MD
Cardiorenal Collaboration: Optimizing Multidisciplinary Care in the CvRM Patient
Raymond Townsend, MD
Michael Weber, MD
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
David Wheeler, MB, CHB, MD, FRCP
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Christina Economides, MD
Brian Howard, MD
David N. Kenigsberg, MD, FACC
Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice
Hongya Chen, PharmD
Jennifer Day, PharmD
Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
Nirav Y. Raval, MD, FACC
Gurusher Panjrath, MD, FACC, FAHA, FHFSA
Tackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
Javed Butler, MD
John P. Boehmer, MD
Direct from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
Marat Fudim, MD, MHS
Experts Discuss Longevity and Durability with TAVR
Suzanne J. Baron, MD
Jonathan A. Bradlow, MD, FACC
Kendra J. Grubb, MD
AFFIRM-AHF: Key Takeaways
Ewa A. Jankowska, MD, PhD, FESC